Ten‐Year Review of Antihypertensive Prescribing Practices After Stroke and the Associated Disparities From the Florida Stroke Registry

Background Guideline‐based hypertension management is integral to the prevention of stroke. We examine trends in antihypertensive medications prescribed after stroke and assess how well a prescriber's blood pressure (BP) medication choice adheres to clinical practice guidelines (BP‐guideline ad...

Full description

Bibliographic Details
Main Authors: Gillian Gordon Perue, Hao Ying, Antonio Bustillo, Lili Zhou, Carolina M. Gutierrez, Hannah E. Gardener, Judith Krigman, Angus Jameson, Chuanhui Dong, Tatjana Rundek, David Z. Rose, Jose G. Romano, Ayham Alkhachroum, Ralph L. Sacco, Negar Asdaghi, Sebastian Koch
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.123.030272
_version_ 1827697389729742848
author Gillian Gordon Perue
Hao Ying
Antonio Bustillo
Lili Zhou
Carolina M. Gutierrez
Hannah E. Gardener
Judith Krigman
Angus Jameson
Chuanhui Dong
Tatjana Rundek
David Z. Rose
Jose G. Romano
Ayham Alkhachroum
Ralph L. Sacco
Negar Asdaghi
Sebastian Koch
author_facet Gillian Gordon Perue
Hao Ying
Antonio Bustillo
Lili Zhou
Carolina M. Gutierrez
Hannah E. Gardener
Judith Krigman
Angus Jameson
Chuanhui Dong
Tatjana Rundek
David Z. Rose
Jose G. Romano
Ayham Alkhachroum
Ralph L. Sacco
Negar Asdaghi
Sebastian Koch
author_sort Gillian Gordon Perue
collection DOAJ
description Background Guideline‐based hypertension management is integral to the prevention of stroke. We examine trends in antihypertensive medications prescribed after stroke and assess how well a prescriber's blood pressure (BP) medication choice adheres to clinical practice guidelines (BP‐guideline adherence). Methods and Results The FSR (Florida Stroke Registry) uses statewide data prospectively collected for all acute stroke admissions. Based on established guidelines, we defined optimal BP‐guideline adherence using the following hierarchy of rules: (1) use of an angiotensin‐converting enzyme inhibitor or angiotensin receptor blocker as first‐line antihypertensive among diabetics; (2) use of thiazide‐type diuretics or calcium channel blockers among Black patients; (3) use of beta blockers among patients with compelling cardiac indication; (4) use of thiazide, angiotensin‐converting enzyme inhibitor/angiotensin receptor blocker, or calcium channel blocker class as first line in all others; (5) beta blockers should be avoided as first line unless there is a compelling cardiac indication. A total of 372 254 cases from January 2010 to March 2020 are in the FSR with a diagnosis of acute ischemic stroke, hemorrhagic stroke, transient ischemic attack, or subarachnoid hemorrhage; 265 409 with complete data were included in the final analysis. Mean age was 70±14 years; 50% were women; and index stroke subtypes were 74% acute ischemic stroke, 11% intracerebral hemorrhage, 11% transient ischemic attack, and 4% subarachnoid hemorrhage. BP‐guideline adherence to each specific rule ranged from 48% to 74%, which is below quality standards of 80%, and was lower among Black patients (odds ratio, 0.7 [95% CI, 0.7–0.83]; P<0.001) and those with atrial fibrillation (odds ratio, 0.53 [95% CI, 0.50–0.56]; P<0.001) and diabetes (odds ratio, 0.65 [95% CI, 0.61–0.68]; P<0.001). Conclusions This large data set demonstrates consistently low rates of BP‐guideline adherence over 10 years. There is an opportunity for monitoring hypertensive management after stroke.
first_indexed 2024-03-10T13:09:19Z
format Article
id doaj.art-0df465e4958048e0be8f018736851175
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-03-10T13:09:19Z
publishDate 2023-11-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-0df465e4958048e0be8f0187368511752023-11-21T10:53:12ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802023-11-01122210.1161/JAHA.123.030272Ten‐Year Review of Antihypertensive Prescribing Practices After Stroke and the Associated Disparities From the Florida Stroke RegistryGillian Gordon Perue0Hao Ying1Antonio Bustillo2Lili Zhou3Carolina M. Gutierrez4Hannah E. Gardener5Judith Krigman6Angus Jameson7Chuanhui Dong8Tatjana Rundek9David Z. Rose10Jose G. Romano11Ayham Alkhachroum12Ralph L. Sacco13Negar Asdaghi14Sebastian Koch15Department of Neurology, Leonard M. Miller School of Medicine University of Miami Miami FLDepartment of Neurology, Leonard M. Miller School of Medicine University of Miami Miami FLDepartment of Neurology, Leonard M. Miller School of Medicine University of Miami Miami FLDepartment of Neurology, Leonard M. Miller School of Medicine University of Miami Miami FLDepartment of Neurology, Leonard M. Miller School of Medicine University of Miami Miami FLDepartment of Neurology, Leonard M. Miller School of Medicine University of Miami Miami FLDepartment of Neurology, Leonard M. Miller School of Medicine University of Miami Miami FLUniversity of South Florida Morsani College of Medicine Tampa FLDepartment of Neurology, Leonard M. Miller School of Medicine University of Miami Miami FLDepartment of Neurology, Leonard M. Miller School of Medicine University of Miami Miami FLUniversity of South Florida Morsani College of Medicine Tampa FLDepartment of Neurology, Leonard M. Miller School of Medicine University of Miami Miami FLDepartment of Neurology, Leonard M. Miller School of Medicine University of Miami Miami FLDepartment of Neurology, Leonard M. Miller School of Medicine University of Miami Miami FLDepartment of Neurology, Leonard M. Miller School of Medicine University of Miami Miami FLDepartment of Neurology, Leonard M. Miller School of Medicine University of Miami Miami FLBackground Guideline‐based hypertension management is integral to the prevention of stroke. We examine trends in antihypertensive medications prescribed after stroke and assess how well a prescriber's blood pressure (BP) medication choice adheres to clinical practice guidelines (BP‐guideline adherence). Methods and Results The FSR (Florida Stroke Registry) uses statewide data prospectively collected for all acute stroke admissions. Based on established guidelines, we defined optimal BP‐guideline adherence using the following hierarchy of rules: (1) use of an angiotensin‐converting enzyme inhibitor or angiotensin receptor blocker as first‐line antihypertensive among diabetics; (2) use of thiazide‐type diuretics or calcium channel blockers among Black patients; (3) use of beta blockers among patients with compelling cardiac indication; (4) use of thiazide, angiotensin‐converting enzyme inhibitor/angiotensin receptor blocker, or calcium channel blocker class as first line in all others; (5) beta blockers should be avoided as first line unless there is a compelling cardiac indication. A total of 372 254 cases from January 2010 to March 2020 are in the FSR with a diagnosis of acute ischemic stroke, hemorrhagic stroke, transient ischemic attack, or subarachnoid hemorrhage; 265 409 with complete data were included in the final analysis. Mean age was 70±14 years; 50% were women; and index stroke subtypes were 74% acute ischemic stroke, 11% intracerebral hemorrhage, 11% transient ischemic attack, and 4% subarachnoid hemorrhage. BP‐guideline adherence to each specific rule ranged from 48% to 74%, which is below quality standards of 80%, and was lower among Black patients (odds ratio, 0.7 [95% CI, 0.7–0.83]; P<0.001) and those with atrial fibrillation (odds ratio, 0.53 [95% CI, 0.50–0.56]; P<0.001) and diabetes (odds ratio, 0.65 [95% CI, 0.61–0.68]; P<0.001). Conclusions This large data set demonstrates consistently low rates of BP‐guideline adherence over 10 years. There is an opportunity for monitoring hypertensive management after stroke.https://www.ahajournals.org/doi/10.1161/JAHA.123.030272blood pressuredisparitiesethnicityFloridahypertensionrace
spellingShingle Gillian Gordon Perue
Hao Ying
Antonio Bustillo
Lili Zhou
Carolina M. Gutierrez
Hannah E. Gardener
Judith Krigman
Angus Jameson
Chuanhui Dong
Tatjana Rundek
David Z. Rose
Jose G. Romano
Ayham Alkhachroum
Ralph L. Sacco
Negar Asdaghi
Sebastian Koch
Ten‐Year Review of Antihypertensive Prescribing Practices After Stroke and the Associated Disparities From the Florida Stroke Registry
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
blood pressure
disparities
ethnicity
Florida
hypertension
race
title Ten‐Year Review of Antihypertensive Prescribing Practices After Stroke and the Associated Disparities From the Florida Stroke Registry
title_full Ten‐Year Review of Antihypertensive Prescribing Practices After Stroke and the Associated Disparities From the Florida Stroke Registry
title_fullStr Ten‐Year Review of Antihypertensive Prescribing Practices After Stroke and the Associated Disparities From the Florida Stroke Registry
title_full_unstemmed Ten‐Year Review of Antihypertensive Prescribing Practices After Stroke and the Associated Disparities From the Florida Stroke Registry
title_short Ten‐Year Review of Antihypertensive Prescribing Practices After Stroke and the Associated Disparities From the Florida Stroke Registry
title_sort ten year review of antihypertensive prescribing practices after stroke and the associated disparities from the florida stroke registry
topic blood pressure
disparities
ethnicity
Florida
hypertension
race
url https://www.ahajournals.org/doi/10.1161/JAHA.123.030272
work_keys_str_mv AT gilliangordonperue tenyearreviewofantihypertensiveprescribingpracticesafterstrokeandtheassociateddisparitiesfromthefloridastrokeregistry
AT haoying tenyearreviewofantihypertensiveprescribingpracticesafterstrokeandtheassociateddisparitiesfromthefloridastrokeregistry
AT antoniobustillo tenyearreviewofantihypertensiveprescribingpracticesafterstrokeandtheassociateddisparitiesfromthefloridastrokeregistry
AT lilizhou tenyearreviewofantihypertensiveprescribingpracticesafterstrokeandtheassociateddisparitiesfromthefloridastrokeregistry
AT carolinamgutierrez tenyearreviewofantihypertensiveprescribingpracticesafterstrokeandtheassociateddisparitiesfromthefloridastrokeregistry
AT hannahegardener tenyearreviewofantihypertensiveprescribingpracticesafterstrokeandtheassociateddisparitiesfromthefloridastrokeregistry
AT judithkrigman tenyearreviewofantihypertensiveprescribingpracticesafterstrokeandtheassociateddisparitiesfromthefloridastrokeregistry
AT angusjameson tenyearreviewofantihypertensiveprescribingpracticesafterstrokeandtheassociateddisparitiesfromthefloridastrokeregistry
AT chuanhuidong tenyearreviewofantihypertensiveprescribingpracticesafterstrokeandtheassociateddisparitiesfromthefloridastrokeregistry
AT tatjanarundek tenyearreviewofantihypertensiveprescribingpracticesafterstrokeandtheassociateddisparitiesfromthefloridastrokeregistry
AT davidzrose tenyearreviewofantihypertensiveprescribingpracticesafterstrokeandtheassociateddisparitiesfromthefloridastrokeregistry
AT josegromano tenyearreviewofantihypertensiveprescribingpracticesafterstrokeandtheassociateddisparitiesfromthefloridastrokeregistry
AT ayhamalkhachroum tenyearreviewofantihypertensiveprescribingpracticesafterstrokeandtheassociateddisparitiesfromthefloridastrokeregistry
AT ralphlsacco tenyearreviewofantihypertensiveprescribingpracticesafterstrokeandtheassociateddisparitiesfromthefloridastrokeregistry
AT negarasdaghi tenyearreviewofantihypertensiveprescribingpracticesafterstrokeandtheassociateddisparitiesfromthefloridastrokeregistry
AT sebastiankoch tenyearreviewofantihypertensiveprescribingpracticesafterstrokeandtheassociateddisparitiesfromthefloridastrokeregistry